RCMI Coordinating Center (RCMI CC) Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Hernandez, Eliud
PropertyValue
overview Dr. Hernandez-O’Farrill is Assistant Professor of Medicinal Chemistry, University of Puerto Rico, School of Pharmacy. Dr. Hernandez-O’Farrill received his BS from the Interamerican University in 1998, a PhD from University of Puerto Rico, Rio Piedras Campus on 2006. Post-doctoral research in Drug Discovery: Medicinal Chemistry, University of Puerto Rico, Medical Sciences Campus, School of Pharmacy. Research efforts target the synthesis of small molecule inhibitors of Rac1 as anti-invasive breast cancer compounds. Rho family GTPases are molecular switches that control signaling pathways regulating a myriad of cellular functions. Rac1, a Rho family member, plays a critical role in several aspects of tumorigenesis and cancer progression, and has been associated with the increased proliferation and invasion of several breast cancer cell lines. Since the activation of Rho GTPases is controlled by guanine nucleotide exchange factors (GEFs), inhibition of the interaction of Rac with its GEFs is a targeted strategy for blocking Rac activation. Dr. Hernández-O’Farrill’s research is supported by institutional matching funds from the NCRR-RCMI Program at the UPR-Medical Sciences Campus for the project: “Small Molecule Inhibitors of Rac1 as AntiInvasive Breast Cancer Compounds”.
One or more keywords matched the following items that are connected to Hernandez, Eliud
Search Criteria
  • rho GTP Binding Proteins
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support